Charles L. Sentman

Best Publications

• bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes.

  Charles L. Sentman;John R. Shutter;David Hockenbery;Osami Kanagawa

  1604
  Citations

• Innate and adaptive immunity in female genital tract: cellular responses and interactions.

  Charles R. Wira;John V. Fahey;Charles L. Sentman;Patricia A. Pioli

  700
  Citations

• Bispecific T-cell engagers for cancer immunotherapy

  Amelia M Huehls;Tiffany A Coupet;Charles L Sentman

  529
  Citations

• Biopolymer implants enhance the efficacy of adoptive T-cell therapy

  Sirkka B Stephan;Alexandria M Taber;Ilona Jileaeva;Ericka P Pegues

  522
  Citations

• Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

  Susanne H. Baumeister;Joana Murad;Lillian Werner;Heather Daley

  357
  Citations

• NKG2D ligands as therapeutic targets

  Paul Spear;Ming-Ru Wu;Marie-Louise Sentman;Charles L. Sentman

  290
  Citations

• NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.

  Tobias Weiss;Michael Weller;Matthias Guckenberger;Charles L Sentman

  274
  Citations

• Vascular Endothelial Growth Factor C Facilitates Immune Tolerance and Endovascular Activity of Human Uterine NK Cells at the Maternal-Fetal Interface

  Satyan S. Kalkunte;Teddy F. Mselle;Wendy E. Norris;Charles R. Wira

  258
  Citations

• Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity

  Juan R. Cubillos-Ruiz;Xavier Engle;Uciane K. Scarlett;Diana Martinez

  251
  Citations

• Host MHC class I gene control of NK-cell specificity in the mouse.

  Petter Hoglund;Jonas Sundback;Mats Y. Olsson-Alheim;Maria Johansson

  225
  Citations

• Recruitment of Uterine NK Cells: Induction of CXC Chemokine Ligands 10 and 11 in Human Endometrium by Estradiol and Progesterone

  Charles L. Sentman;Sarah K. Meadows;Charles R. Wira;Mikael Eriksson

  218
  Citations

• Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts.

  C L Sentman;J Hackett;V Kumar;M Bennett

  201
  Citations

• Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-β

  Mikael Eriksson;Sarah K. Meadows;Charles R. Wira;Charles L. Sentman

  198
  Citations

• Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapy

  Tong Zhang;Bethany A. Lemoi;Charles L. Sentman

  195
  Citations

• Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand.

  Mats Y. Olsson;Klas Karre;Charles L. Sentman

  187
  Citations

• Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor

  Tong Zhang;Amorette Barber;Charles L. Sentman

  175
  Citations

• Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

  Eduardo Huarte;Juan R. Cubillos-Ruiz;Yolanda C. Nesbeth;Uciane K. Scarlett

  169
  Citations

• An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo

  Tong Zhang;Ming-Ru Wu;Charles L. Sentman

  158
  Citations

• NKG2D CARs as cell therapy for cancer.

  Charles L. Sentman;Kenneth R. Meehan

  156
  Citations

• Acquisition of External Major Histocompatibility Complex Class I Molecules by Natural Killer Cells Expressing Inhibitory Ly49 Receptors

  Anna Sjöström;Mikael Eriksson;Cristina Cerboni;Maria H. Johansson

  147
  Citations